Originally posted here:
AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development of ABP-450 Across Several Therapeutic Indications

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh